It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis

Rezafungin is a long-acting echinocandin with broad coverage against Candida. Rezafungin has primarily been indicated for candidemia, with limited literature available on its use for infections outside of the bloodstream. Herein, three patient cases are presented from an academic medical center. Infectious processes presented include drug-resistant mucosal candidiasis, prosthetic joint infection, and candidemia involving Candida auris. In all three cases, patients received rezafungin. Clinical response was demonstrated in all patients as was tolerability of rezafungin. Together these cases provide further evidence for the use of rezafungin, including its use for treatment of invasive infections other than candidemia.

Authors

Institutions

Publication Details

Journal
Infectious Diseases and Therapy
Published
2025-03-11
DOI
https://doi.org/10.1007/s40121-025-01120-7
Citations
5
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
6.98
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis

Robert W. Bradsher, Jacob M. Keck, Alina Viteri, Juan Carlos Rico et al.
5 citations
Infectious Diseases and Therapy
Antifungal resistance and susceptibility
6.98
article

It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis

Robert W. Bradsher, Jacob M. Keck, Alina Viteri, Juan Carlos Rico, Ryan K Dare, Jennifer L. McDonald, Megan Jenkins, Luke Grisham
article en
5 citations

Abstract

Rezafungin is a long-acting echinocandin with broad coverage against Candida. Rezafungin has primarily been indicated for candidemia, with limited literature available on its use for infections outside of the bloodstream. Herein, three patient cases are presented from an academic medical center. Infectious processes presented include drug-resistant mucosal candidiasis, prosthetic joint infection, and candidemia involving Candida auris. In all three cases, patients received rezafungin. Clinical response was demonstrated in all patients as was tolerability of rezafungin. Together these cases provide further evidence for the use of rezafungin, including its use for treatment of invasive infections other than candidemia.

Infectious Diseases and TherapyVol. 14(4)
University of Arkansas for Medical Sciences (US)
Zero hunger
Openalex Percentile: Top 3%
Antifungal resistance and susceptibility
6.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis — Robert W. Bradsher, Jacob M. Keck, et al. · Infectious Diseases and Therapy (2025) | TGRS Research Map | TGRS